Palifermin for prevention of oral mucositis in allogeneic hematopoietic stem cell transplantation: a single-institution retrospective evaluation

[1] Hensley ML(2008)American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: use of Chemotherapy and Radiation Therapy Protectants J Clin Oncol 27 127-145

[2] Hagerty KL(2012)Oral complications of cancer and cancer therapy: from cancer treatment to survivorship Cancer J Clin 62 400-422

[3] Kewalramani T(1993)A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients Cancer 72 1612-1617

[4] Epstein JB(2014)Basic oral care for hematology-oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the joint task force of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EMBT) Support Care Cancer 120 1453-1461

[5] Thariat J(2014)MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy Cancer 21 1621-1627

[6] Bensadoun RJ(2013)Periodontal status and bacteremia with oral viridans streptococci and coagulase negative staphylococci in allogeneic hematopoietic stem cell transplantation recipients: a prospective observational study Support Care Cancer 100 1995-2025

[7] Woo SB(2004)Perspectives on cancer therapy-induced mucosal injury Cancer 19 2201-2205

[8] Sonis ST(2001)Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation J Clin Oncol 21 343-355

[9] Monopoli MM(2013)Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients Support Care Cancer 58 933-939

[10] Elad S(1998)Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality Cancer Res 108 3216-3221

[1] Hensley ML(2008)American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: use of Chemotherapy and Radiation Therapy Protectants J Clin Oncol 27 127-145

[2] Hagerty KL(2012)Oral complications of cancer and cancer therapy: from cancer treatment to survivorship Cancer J Clin 62 400-422

[3] Kewalramani T(1993)A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients Cancer 72 1612-1617

[4] Epstein JB(2014)Basic oral care for hematology-oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the joint task force of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EMBT) Support Care Cancer 120 1453-1461

[5] Thariat J(2014)MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy Cancer 21 1621-1627

[6] Bensadoun RJ(2013)Periodontal status and bacteremia with oral viridans streptococci and coagulase negative staphylococci in allogeneic hematopoietic stem cell transplantation recipients: a prospective observational study Support Care Cancer 100 1995-2025

[7] Woo SB(2004)Perspectives on cancer therapy-induced mucosal injury Cancer 19 2201-2205

[8] Sonis ST(2001)Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation J Clin Oncol 21 343-355

[9] Monopoli MM(2013)Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients Support Care Cancer 58 933-939

[10] Elad S(1998)Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality Cancer Res 108 3216-3221